ArticleHaematologica2023

Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells.

Yannan Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.